Literature DB >> 25907354

Proceedings of the ASNC Cardiac PET Summit, 12 May 2014, Baltimore, MD : 1: The value of PET: Integrating cardiovascular PET into the care continuum.

Rob Beanlands1, Gary V Heller.   

Abstract

Mesh：

Year:  2015        PMID： 25907354     DOI： 10.1007/s12350-015-0129-0

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  23 in total

1.  Does imaging-guided selection of patients with ischemic heart failure for high risk revascularization improve identification of those with the highest clinical benefit?: Imaging-guided selection of patients with ischemic heart failure for high-risk revascularization improves identification of those with the highest clinical benefit.

Authors:  Lisa M Mielniczuk; Rob S Beanlands
Journal:  Circ Cardiovasc Imaging       Date:  2012-03       Impact factor: 7.792

2.  Impact of myocardial perfusion imaging with PET and (82)Rb on downstream invasive procedure utilization, costs, and outcomes in coronary disease management.

Authors:  Michael E Merhige; William J Breen; Victoria Shelton; Teresa Houston; Brian J D'Arcy; Anthony F Perna
Journal:  J Nucl Med       Date:  2007-07       Impact factor: 10.057

3.  Myocardial viability and survival in ischemic left ventricular dysfunction.

Authors:  Robert O Bonow; Gerald Maurer; Kerry L Lee; Thomas A Holly; Philip F Binkley; Patrice Desvigne-Nickens; Jaroslaw Drozdz; Pedro S Farsky; Arthur M Feldman; Torsten Doenst; Robert E Michler; Daniel S Berman; Jose C Nicolau; Patricia A Pellikka; Krzysztof Wrobel; Nasri Alotti; Federico M Asch; Liliana E Favaloro; Lilin She; Eric J Velazquez; Robert H Jones; Julio A Panza
Journal:  N Engl J Med       Date:  2011-04-04       Impact factor: 91.245

4.  F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2).

Authors:  Rob S B Beanlands; Graham Nichol; Ella Huszti; Dennis Humen; Normand Racine; Michael Freeman; Karen Y Gulenchyn; Linda Garrard; Robert deKemp; Ann Guo; Terrence D Ruddy; Francois Benard; André Lamy; Robert M Iwanochko
Journal:  J Am Coll Cardiol       Date:  2007-10-10       Impact factor: 24.094

5.  Incremental prognostic value of gated Rb-82 positron emission tomography myocardial perfusion imaging over clinical variables and rest LVEF.

Authors:  Sharmila Dorbala; Rory Hachamovitch; Zelmira Curillova; Deepak Thomas; Divya Vangala; Raymond Y Kwong; Marcelo F Di Carli
Journal:  JACC Cardiovasc Imaging       Date:  2009-07

6.  Independent and incremental prognostic value of left ventricular ejection fraction determined by stress gated rubidium 82 PET imaging in patients with known or suspected coronary artery disease.

Authors:  Kirkeith Lertsburapa; Alan W Ahlberg; Timothy M Bateman; Deborah Katten; Lyndy Volker; S James Cullom; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2008-09-12       Impact factor: 5.952

7.  Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction: inducible ischemia versus hibernating myocardium.

Authors:  Lee Fong Ling; Thomas H Marwick; Demetrio Roland Flores; Wael A Jaber; Richard C Brunken; Manuel D Cerqueira; Rory Hachamovitch
Journal:  Circ Cardiovasc Imaging       Date:  2013-04-17       Impact factor: 7.792

8.  Prognostic value of stress myocardial perfusion positron emission tomography: results from a multicenter observational registry.

Authors:  Sharmila Dorbala; Marcelo F Di Carli; Rob S Beanlands; Michael E Merhige; Brent A Williams; Emir Veledar; Benjamin J W Chow; James K Min; Michael J Pencina; Daniel S Berman; Leslee J Shaw
Journal:  J Am Coll Cardiol       Date:  2012-12-05       Impact factor: 24.094

9.  Diagnostic accuracy of rest/stress ECG-gated Rb-82 myocardial perfusion PET: comparison with ECG-gated Tc-99m sestamibi SPECT.

Authors:  Timothy M Bateman; Gary V Heller; A Iain McGhie; John D Friedman; James A Case; Jan R Bryngelson; Ginger K Hertenstein; Kelly L Moutray; Kimberly Reid; S James Cullom
Journal:  J Nucl Cardiol       Date:  2006 Jan-Feb       Impact factor: 5.952

10.  Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) IMAGE HF Project I-A: study protocol for a randomized controlled trial.

Authors:  Eileen O'Meara; Lisa M Mielniczuk; George A Wells; Robert A deKemp; Ran Klein; Doug Coyle; Brian Mc Ardle; Ian Paterson; James A White; Malcolm Arnold; Matthias G Friedrich; Eric Larose; Alexander Dick; Benjamin Chow; Carole Dennie; Haissam Haddad; Terrence Ruddy; Heikki Ukkonen; Gerald Wisenberg; Bernard Cantin; Philippe Pibarot; Michael Freeman; Eric Turcotte; Kim Connelly; James Clarke; Kathryn Williams; Normand Racine; Linda Garrard; Jean-Claude Tardif; Jean DaSilva; Juhani Knuuti; Rob Beanlands
Journal:  Trials       Date:  2013-07-16       Impact factor: 2.279
View more
  2 in total

Review 1.  Clinical use of quantitative cardiac perfusion PET: rationale, modalities and possible indications. Position paper of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM).

Authors:  Roberto Sciagrà; Alessandro Passeri; Jan Bucerius; Hein J Verberne; Riemer H J A Slart; Oliver Lindner; Alessia Gimelli; Fabien Hyafil; Denis Agostini; Christopher Übleis; Marcus Hacker
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-02-05       Impact factor: 9.236

Review 2.  Coronary microvascular dysfunction in women with nonobstructive ischemic heart disease as assessed by positron emission tomography.

Authors:  Roxana Campisi; Fernando D Marengo
Journal:  Cardiovasc Diagn Ther       Date:  2017-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.